Literature DB >> 2110930

Cocultivation of Fanconi anemia cells and of mouse lymphoma mutants leads to interspecies complementation of chromosomal hypersensitivity to DNA cross-linking agents.

F Rosselli1, E Moustacchi.   

Abstract

We have studied the effects of cocultivation on the frequency of mitomycin C (MMC)-induced chromosomal aberrations. This was carried out by cocultivating Fanconi anemia (FA) cells from the genetic complementation groups A and B with both normal mouse lymphoma L5178Y cells and the derived "FA-like" mutant cells, MCN-151 and MCE-50, assigned to complementation groups I and II, respectively. The results show a partial complementation of the defect (i.e. a reduction in the frequency of chromosomal aberration) in FA group A cells cocultured with normal or group II mouse cells, and a partial correction of mouse group I cells cocultived with normal or FA group B human cells. No reciprocal effects were observed between FA group A cells and mouse group I mutant cells; the frequencies of MMC-induced chromosomal aberrations in these cells remained unchanged by cocultivation. Moreover, no complementation was observed for both FA group B cells and mouse group II cells, after cocultivation with normal cells of either mouse or human origin. This implies that a diffusible factor released by normal human and mouse cells, and by FA group B and mouse group II mutant cells, can correct at least in part the chromosomal defect of FA group A and mouse group I mutant cells. With normal human or mouse cells, the frequency of chromosomal breakage after cocultivation remains the same as that observed in non-cocultived cells. This suggests that no detectable clastogenic factor is released by human FA or "FA-like" mouse cells.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2110930     DOI: 10.1007/bf00210801

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  15 in total

1.  Susceptibility of Fanconi's anaemia fibroblasts to chromosome damage by carcinogens.

Authors:  A D Auerbach; S R Wolman
Journal:  Nature       Date:  1976-06-10       Impact factor: 49.962

2.  Chromosomal hypersensitivity in mutant MCN-151 mouse cells exposed to mitomycin C.

Authors:  F Rosselli; E Moustacchi
Journal:  Mutat Res       Date:  1989-03       Impact factor: 2.433

3.  A high susceptibility of Fanconi's anemia to chromosome breakage by DNA cross-linking agents.

Authors:  M S Sasaki; A Tonomura
Journal:  Cancer Res       Date:  1973-08       Impact factor: 12.701

4.  [Chromosome abnormalities in constitutional cytopenia].

Authors:  D Germain; C Requin
Journal:  Nouv Rev Fr Hematol       Date:  1970 Jan-Feb

5.  Antagonistic effect of cocultivation on mitomycin C-induced aberration rate in cells of a patient with Fanconi's anemia and in Chinese hamster ovary cells.

Authors:  S Zakrzewski; K Sperling
Journal:  Hum Genet       Date:  1980       Impact factor: 4.132

6.  Chromosome breakage in Fanconi's anemia and normal cells following in vitro and in vivo cocultivation.

Authors:  M Shaham; B Adler
Journal:  Cancer Genet Cytogenet       Date:  1986-12

7.  The cell cycle of lymphocytes in Fanconi anemia.

Authors:  B Dutrillaux; A Aurias; A M Dutrillaux; D Buriot; M Prieur
Journal:  Hum Genet       Date:  1982       Impact factor: 4.132

8.  The fate of 8-methoxypsoralen-photoinduced DNA interstrand crosslinks in Fanconi's anemia cells of defined genetic complementation groups.

Authors:  D Papadopoulo; D Averbeck; E Moustacchi
Journal:  Mutat Res       Date:  1987-11       Impact factor: 2.433

9.  Survival and mutagenic responses of mitomycin C-sensitive mouse lymphoma cell mutants to other DNA cross-linking agents.

Authors:  H Hama-Inaba; K Sato; E Moustacchi
Journal:  Mutat Res       Date:  1988-09       Impact factor: 2.433

10.  Isolation and characterization of mitomycin-C-sensitive mouse lymphoma cell mutants.

Authors:  H Hama-Inaba; N Hieda-Shiomi; T Shiomi; K Sato
Journal:  Mutat Res       Date:  1983-03       Impact factor: 2.433

View more
  3 in total

1.  Partial complementation of the Fanconi anemia defect upon transfection by heterologous DNA. Phenotypic dissociation of chromosomal and cellular hypersensitivity to DNA cross-linking agents.

Authors:  C Diatloff-Zito; F Rosselli; J Heddle; E Moustacchi
Journal:  Hum Genet       Date:  1990-12       Impact factor: 4.132

2.  Abnormal lymphokine production: a novel feature of the genetic disease Fanconi anemia. I. Involvement of interleukin-6.

Authors:  F Rosselli; J Sanceau; J Wietzerbin; E Moustacchi
Journal:  Hum Genet       Date:  1992-04       Impact factor: 4.132

3.  Irreversible repression of DNA synthesis in Fanconi anemia cells is alleviated by the product of a novel cyclin-related gene.

Authors:  M Digweed; U Günthert; R Schneider; H Seyschab; R Friedl; K Sperling
Journal:  Mol Cell Biol       Date:  1995-01       Impact factor: 4.272

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.